title: Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita.
authors.affiliation: Department of Dermatology, University of Lübeck, Lübeck, Germany.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Iwata
authors.affiliation: Department of Dermatology, University of Lübeck, Lübeck, Germany.
authors.forename: Elena
authors.initials: E
authors.lastname: Pipi
authors.affiliation: Department of Dermatology, University of Lübeck, Lübeck, Germany.
authors.forename: Nicole
authors.initials: N
authors.lastname: Möckel
authors.affiliation: SuppreMol GmbH, Munich, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Sondermann
authors.affiliation: Department of Dermatology, University of Lübeck, Lübeck, Germany; Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
authors.forename: Artem
authors.initials: A
authors.lastname: Vorobyev
authors.affiliation: Department of Dermatology, University of Lübeck, Lübeck, Germany.
authors.forename: Nina
authors.initials: N
authors.lastname: van Beek
authors.affiliation: Department of Dermatology, University of Lübeck, Lübeck, Germany; Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
authors.forename: Detlef
authors.initials: D
authors.lastname: Zillikens
authors.affiliation: Department of Dermatology, University of Lübeck, Lübeck, Germany; Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. Electronic address: Ralf.Ludwig@uksh.de.
authors.forename: Ralf J
authors.initials: RJ
authors.lastname: Ludwig
mesh_terms: D000818:Animals; D000936:Antigen-Antibody Complex / Q000378:metabolism; D004195:Disease Models, Animal; D018450:Disease Progression; D016107:Epidermolysis Bullosa Acquisita / Q000378:metabolism / Q000517:prevention & control*; D006801:Humans; D051379:Mice; D017382:Reactive Oxygen Species / Q000378:metabolism; D017452:Receptors, IgG / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000936:Antigen-Antibody Complex; D017382:Reactive Oxygen Species; D017452:Receptors, IgG; D011994:Recombinant Proteins